Be brave enough to find balance.

HomeSafetyOur ProvidersPricingFAQContact

At-Home Ketamine Therapy in Florida

When a provider determines it is clinically appropriate, ketamine treatment can take place at home — within a structured safety framework, with provider oversight at every step.

If you are in crisis or having thoughts of suicide, this is an emergency. Call or text 988 (Suicide & Crisis Lifeline) or call 911. Bravely Balanced is not an emergency service, and the candidate assessment is not a crisis intervention.

At-home ketamine treatment is a clinician-directed option for eligible patients. It is not a DIY regimen and not a guaranteed outcome. Everything about your plan — formulation, strength, dose, and frequency — is determined by your prescribing provider and supported by required follow-up.

How at-home treatment works

After psychiatric evaluation and, if appropriate, a prescription sent to a licensed compounding pharmacy, you receive compounded ketamine and take it in a calm, private setting. Bravely Balanced does not provide IV or IM ketamine; at-home treatment uses oral or nasal formulations only.

Preparing for a session

  • Choose a calm, private, comfortable environment.
  • Avoid food for the time your provider recommends before treatment.
  • No alcohol or recreational substances in the 24 hours beforehand.
  • Have your support person available.
  • Confirm no driving or machinery for the remainder of the treatment day.

Administration principles

Administration follows your provider's specific instructions for your prescribed formulation — nasal spray, troches, or ODT. You do not adjust your dose. If you have questions or experience unexpected effects, you contact your provider through the secure portal rather than self-managing.

Support person requirement

A trusted support person should be nearby or available by phone during sessions, particularly early in treatment. Their role is simple but important: stay reachable, keep the environment calm, and help you follow safety guidance.

The first 30-day safety framework

The first month is structured to prioritize safety. You log each treatment session, track mood before and after, and complete required follow-up. Your provider reviews this data before deciding whether and how to continue.

Provider monitoring

Follow-up is not optional. Your provider assesses symptom change, functioning, side effects, and whether ketamine continues to be appropriate. Continuation is never automatic — it is a clinical decision made at each visit.

When at-home treatment is not appropriate

At-home treatment may not be appropriate if you cannot maintain a safe environment, lack a support person, have contraindications such as uncontrolled hypertension or active psychosis, or need a higher level of care than telehealth can provide. In those cases, your provider will discuss alternatives or referrals.

Safety at home

At-home treatment is only appropriate when it can be done safely. The program is built around preparation, a support person, structured logging, and required follow-up — not around unsupervised self-treatment. See our safety standards for a full overview.

Important context about ketamine. Ketamine is FDA-approved as an anesthetic. The use of compounded racemic ketamine for psychiatric conditions is off-label, and compounded medications are not FDA-approved products. Compounded ketamine nasal spray is not the same as FDA-approved esketamine (Spravato®).

Treatment is not appropriate for everyone. A licensed clinician independently determines whether prescribing is appropriate. No prescription is guaranteed, and completing an assessment does not equal clinical eligibility.

About this page

Written by:
Bravely Balanced Clinical Education Team
Medical review:
Pending — this content has not yet been clinically reviewed.
Last updated:
2026-08-27

This page is educational and is not a substitute for personalized medical advice. All treatment decisions are made by a licensed provider based on your individual evaluation.

Your next step

Start with a secure candidate assessment. A licensed provider reviews your information and determines whether ketamine treatment may be clinically appropriate for you.

Assessment completion does not equal clinical eligibility.